Gene · 2646
Papers2,346
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,346
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PNPLA3 Is Associated With Hepatocellular Carcinoma, While a Five-Variant Polygenic Risk Score Shows Limited Discrimination in Korean Patients With MASLD. | J Gastroenterol Hepatol | 2026 | 42802015 | PubTator, text mining | PubMed |
| Polymorphic Variant Associated with Sex Hormone-Binding Globulin Level Is a Risk Factor for Preeclampsia. | Int J Mol Sci | 2026 | 42794813 | PubTator, text mining | PubMed |
| GeneSIS: enhancing transferability of polygenic scores with variant-level gene-by-sex interaction effects. | bioRxiv | 2026 | 42779975 | PubTator, text mining | PubMed |
| Ultra-rapid progression of MAFLD to cirrhosis and post-transplant steatosis in a patient with a polygenic risk profile. | MedScience | 2026 | 42758280 | PubTator, text mining | PubMed |
| Liver Fibrosis and IRS1 rs2972146 Are Associated With Weight Loss Response After Metabolic Bariatric Surgery. | Diabetes Obes Metab | 2026 | 42755140 | PubTator, text mining | PubMed |
| MBOAT7 rs641738 TT genotype is associated with poorer survival in MASLD-related hepatocellular carcinoma. | Front Oncol | 2026 | 42656337 | PubTator, text mining | PubMed |
| Beyond Fat: Reframing MASLD Through Genetics, Clonal Biology, and Precision Hepatology. | Pharmaceuticals (Basel) | 2026 | 42653643 | PubTator, text mining | PubMed |
| Purine-Metabolism Reprogramming Associated with Failed-Repair Proximal Tubule States in the AKI-to-CKD Transition. | Metabolites | 2026 | 42646274 | PubTator, text mining | PubMed |
| Elucidating the proteomic pathways linking childhood body mass index with type 2 diabetes: a Mendelian randomization and recall-by-genotype study. | Int J Epidemiol | 2026 | 42613030 | PubTator, text mining | PubMed |
| Exploring the role of inflammatory cytokines in obesity-mediated MASLD development and drug target identification. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 42587048 | PubTator, text mining | PubMed |
| Large-Scale Analyses of GWAS Identify Five Key Pleiotropic Genes Involved in Complex Diseases. | Genes (Basel) | 2026 | 42510806 | PubTator, text mining | PubMed |
| Genetic determinants of gestational diabetes mellitus in thai pregnant women: role of GCKR, CDKAL1, TCF7L2, NEDD1, and CMIP variants. | Ann Med | 2026 | 42466846 | PubTator, text mining | PubMed |
| Cross-definition GWAS of IBS in 2.8 million individuals reveals cardiometabolic and triglyceride-linked mechanisms. | Gut | 2026 | 42425734 | PubTator, text mining | PubMed |
| Roles of circulating proteins in osteoporosis pathogenesis: Insights from Mendelian randomization. | Bone | 2026 | 42419582 | PubTator, text mining | PubMed |
| Genetic and genomic insights across the steatotic liver disease spectrum. | Clin Mol Hepatol | 2026 | 42366560 | PubTator, text mining | PubMed |
| Multi-ancestry genome-wide association meta-analysis of hepatocellular carcinoma identifies 15 risk loci including MAP3K9, DHRS1, MTTP, and 8q24.21. | HGG Adv | 2026 | 42357869 | PubTator, text mining | PubMed |
| Glucokinase Regulatory Protein Gene Polymorphism as a Predictive Biomarker for Early Renal Injury in Newly Diagnosed Early-Onset Type 2 Diabetes Mellitus. | Diabetes Metab Res Rev | 2026 | 42339691 | PubTator, text mining | PubMed |
| Egyptian MASLD genetic map; between the leading TM6SF2 gene and role of epigenetic. | J Appl Genet | 2026 | 42287598 | PubTator, text mining | PubMed |
| Global trends in metabolic-associated hepatocellular carcinoma: genetic and socio-demographic drivers. | Hepatol Int | 2026 | 42274972 | PubTator, text mining | PubMed |
| LiRNA: An interactive atlas of human liver RNAseq databases. | JHEP Rep | 2026 | 42264302 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2646/papers